Take actions to bridge the gaps between China and other countries: in the aspect of markers of mineral bone disease from China Dialysis Outcomes and Practice Patterns Study phase 5

Abstract

Chinese National Renal Data System is the first national relatively stricter target than North America and Europe database for Chinese hemodialysis (HD) population, but (but on par with facility directors in Japan), genetic lower unfortunately, data of monitoring frequency of laboratory markers were not well recorded, and therapeutic information was not timely updated. So China Dialysis Outcomes and Practice Patterns Study (DOPPS) is a representative of Chinese HD patients with close following, as compared with data of other countries. A total of 1186 patientswere enrolled randomly from 45 HD facilities which were also randomly selected from the metropolitan areas in the three largest cities in China (Beijing, Guangzhou, and Shanghai, not in smaller cities or rural areas) from 2012 to 2015. So the study population in China DOPPS cannot be viewed as representative of the whole ChineseHD population, or an updated one. But considering the fact that up to now, a lack of therapeutic medicine was still commonly seen in some hospitals, gaps were significant and more actions were needed, when China DOPPS data were compared with other countries.